Skip to main navigation

close

About
Pipeline
- Our pipeline
- Publications
Programs
- Cardiac programs
- CNS programs
  - Alzheimer's
Patients
Careers
Investors

Location

345 Park Ave South,
New York, NY 10010
(212) 547-9879

General Information
info@lexeotx.com (212) 547-9879
Investor Inquiries
investors@lexeotx.com
Media Inquiries
media@lexeotx.com
LinkedIn
Follow LEXEO on LinkedIn

Investor Home
News & Events
Financials & Filings
- SEC Filings
- Tax Information
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Governance
Resources

Press Releases

Year

Mar 30, 2026

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Mar 03, 2026

Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference

Feb 05, 2026

Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February

Jan 27, 2026

Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics

Jan 12, 2026

Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy

Jan 08, 2026

Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene Therapy

Contact Us

Investor Inquiries
investors@lexeotx.com
Media Inquiries
media@lexeotx.com

Print page
Email alerts

345 Park Ave South,
New York, NY 10010

info@lexeotx.com

About
Pipeline
- Our pipeline
- Publications
Programs
- Cardiac programs
- CNS programs
Patients
Careers
Investors
Contact us

Subscribe for our latest news

Subscribe

©2025 Lexeo Therapeutics, Inc. All Rights Reserved.

Terms of Use
Privacy Policy